These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5533298)

  • 21. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J; Kaffarnik H
    Med Klin; 1969 May; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract]   [Full Text] [Related]  

  • 22. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

  • 24. Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus.
    Alt N; Kley S; Haessig M; Reusch CE
    J Am Vet Med Assoc; 2007 Apr; 230(7):1011-7. PubMed ID: 17397339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycemic control in the intensive care unit: specifities in diabetic patients].
    Wion-Barbot N; Halimi S
    Ann Fr Anesth Reanim; 2009 May; 28(5):e225-9. PubMed ID: 19410421
    [No Abstract]   [Full Text] [Related]  

  • 27. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cell therapy and gene therapy in diabetes mellitus].
    Seufert J
    MMW Fortschr Med; 2004 May; 146(20):39-40. PubMed ID: 15344732
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of total and separate blood levels of nucleic acids (RNA and DNA) in states of diverse severity of diabetes mellitus and during antidiabetic therapy].
    Zhurova MV; Vediaeva LV
    Ter Arkh; 1980; 52(8):73-7. PubMed ID: 6167002
    [No Abstract]   [Full Text] [Related]  

  • 31. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trust is good, control is better. Glucose tests, insulin syringes, needles].
    Fink E
    Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181
    [No Abstract]   [Full Text] [Related]  

  • 33. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of a new hypoglycemic sulfonamide: glibenclamide].
    Guinet P; Tourniaire J; Ollier C
    Rev Lyon Med; 1970 Oct; 19(16):655-64. PubMed ID: 5532152
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the pathogenesis and therapy of senile diabetes].
    Butturini U
    G Clin Med; 1966 Oct; 47(10):915-26. PubMed ID: 5997188
    [No Abstract]   [Full Text] [Related]  

  • 36. [Constraints to benefits obtained, capillary blood glucose utility in treatment].
    Bodin F
    Rev Infirm; 2008 Jun; (141):18-20. PubMed ID: 18669379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 40. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.